×
About 155,508 results

ALLMedicine™ Colorectal Cancer Center

Research & Reviews  74,789 results

Assessment of quality-of-care indicators for colorectal cancer surgery at a single cent...
https://www.ncbi.nlm.nih.gov/pubmed/33107816
Canadian Journal of Surgery. Journal Canadien De Chirurgie; Vergara-Fernández O, Rangel-Ríos H et. al.

Oct 27th, 2020 - The implementation of quality-of-care indicators aiming to improve colorectal cancer (CRC) outcomes has been previously described by Cancer Care Ontario. The aim of this study was to assess the quality-of-care indicators in CRC at a referral centr...

Factors Influencing Implementation of a Colorectal Cancer Screening Improvement Program...
https://doi.org/10.1007/s11606-020-06186-2
Journal of General Internal Medicine; Petrik AF, Green B et. al.

Oct 27th, 2020 - Evidence-based programs such as mailed fecal immunochemical test (FIT) outreach can only affect health outcomes if they can be successfully implemented. However, attempts to implement programs are often limited by organizational-level factors. As ...

5-Hydroxymethylcytosine signature in circulating cell-free DNA as a potential diagnosti...
https://doi.org/10.1002/1878-0261.12833
Molecular Oncology; Xiao Z, Wu W et. al.

Oct 27th, 2020 - Approximately 85% Colorectal cancers (CRCs) are thought to evolve through the adenoma-to-carcinoma sequence associated with specific molecular alterations, including the 5-hydroxymethylcytosine (5hmC) signature in circulating cell-free DNA (cfDNA)...

Magnetic nanomedicine for CD133-expressing cancer therapy using locoregional hypertherm...
https://doi.org/10.2217/nnm-2020-0222
Nanomedicine (London, England); Yang SJ, Tseng SY et. al.

Oct 26th, 2020 - Aim: Cells with CD133 overexpression, a theoretical cancer stem cells (CSCs) marker, have been shown to induce colorectal cancer (CRC) initiation and relapse. Therefore, the detection and treatment of CSCs are the most important factors in overcom...

Upregulated CNTN1 is associated with lymph node metastasis and poor prognosis of colore...
https://doi.org/10.3233/CBM-190981
Cancer Biomarkers : Section A of Disease Markers; Li G, Zhang Z et. al.

Oct 26th, 2020 - Contactin1 (CNTN1), a member of the immunoglobulin superfamily, is known to correlate with tumor development and progression. Although recent studies have found that elevated CNTN1 has been demonstrated in some types of cancers, the expression and...

see more →

Guidelines  413 results

Recent advances in clinical practice: colorectal cancer chemoprevention in the average-risk population
https://gut.bmj.com/content/early/2020/09/08/gutjnl-2020-320990
Gut Chapelle N

Sep 27th, 2020 - This review evaluates the evidence across 80 meta-analyses of interventional and observational studies of CRC prevention using medications, vitamins, supplements and dietary factors.

Clinical Implications of First-Line Pembro for MSI-High mCRC
https://dailynews.ascopubs.org/do/10.1200/ADN.20.200220/full/

Jun 23rd, 2020 - Long-awaited results from the randomized, phase III KEYNOTE-177 trial provide strong support for using single-agent pembrolizumab instead of a chemotherapy-based regimen in patients newly diagnosed with metastatic colorectal cancer (mCRC) featurin...

Thierry André, MD, on Colorectal Cancer: Pembrolizumab vs Chemotherapy for Metastatic Disease
https://ascopost.com/videos/asco20-virtual-scientific-program/thierry-andre-on-pembrolizumab-vs-chemotherapy-for-metastatic-colorectal-cancer/

May 31st, 2020 - Thierry André, MD, of Hôpital Saint-Antoine, discusses the phase III results from KEYNOTE-177, which showed that, compared with standard chemotherapy of FOLFOX or FOLFIRI, pembrolizumab doubled median progression-free survival, from 8.2 months to...

Scott Kopetz, MD, PhD, on Colorectal Cancer: Encorafenib Plus Cetuximab With or Without Binimetinib
https://ascopost.com/videos/asco20-virtual-scientific-program/scott-kopetz-on-encorafenib-plus-cetuximab-with-or-without-binimetinib-in-colorectal-cancer/

May 29th, 2020 - Scott Kopetz, MD, PhD, of The University of Texas MD Anderson Cancer Center, discusses phase III results of the BEACON CRC study, which confirmed that, compared with standard chemotherapy, encorafenib plus cetuximab with or without binimetinib imp...

HER2-targeted therapy shows antitumor activity in metastatic colorectal cancer
https://www.healio.com/hematology-oncology/gastrointestinal-cancer/news/online/{6840dc0f-5d75-4042-8b28-a618af3ebf99}/her2-targeted-therapy-shows-antitumor-activity-in-metastatic-colorectal-cancer

May 29th, 2020 - Trastuzumab deruxtecan demonstrated durable benefit among patients with HER2-expressing metastatic colorectal cancer, according to findings of the phase 2 DESTINY-CRC01 study presented during the ASCO20 Virtual Scientific Program.

see more →

Drugs  209 results see all →

Clinicaltrials.gov  77,679 results

Assessment of quality-of-care indicators for colorectal cancer surgery at a single cent...
https://www.ncbi.nlm.nih.gov/pubmed/33107816
Canadian Journal of Surgery. Journal Canadien De Chirurgie; Vergara-Fernández O, Rangel-Ríos H et. al.

Oct 27th, 2020 - The implementation of quality-of-care indicators aiming to improve colorectal cancer (CRC) outcomes has been previously described by Cancer Care Ontario. The aim of this study was to assess the quality-of-care indicators in CRC at a referral centr...

Factors Influencing Implementation of a Colorectal Cancer Screening Improvement Program...
https://doi.org/10.1007/s11606-020-06186-2
Journal of General Internal Medicine; Petrik AF, Green B et. al.

Oct 27th, 2020 - Evidence-based programs such as mailed fecal immunochemical test (FIT) outreach can only affect health outcomes if they can be successfully implemented. However, attempts to implement programs are often limited by organizational-level factors. As ...

5-Hydroxymethylcytosine signature in circulating cell-free DNA as a potential diagnosti...
https://doi.org/10.1002/1878-0261.12833
Molecular Oncology; Xiao Z, Wu W et. al.

Oct 27th, 2020 - Approximately 85% Colorectal cancers (CRCs) are thought to evolve through the adenoma-to-carcinoma sequence associated with specific molecular alterations, including the 5-hydroxymethylcytosine (5hmC) signature in circulating cell-free DNA (cfDNA)...

Now USPSTF Also Suggests Start CRC Screening at Age 45
https://www.medscape.com/viewarticle/939820

Oct 26th, 2020 - Screening for colorectal cancer (CRC) should begin at age 45 years instead of 50 years, as recommended in the current guideline, the US Preventive Services Task Force (USPSTF) says in a draft recommendation that is open for public comment. "This i...

Magnetic nanomedicine for CD133-expressing cancer therapy using locoregional hypertherm...
https://doi.org/10.2217/nnm-2020-0222
Nanomedicine (London, England); Yang SJ, Tseng SY et. al.

Oct 26th, 2020 - Aim: Cells with CD133 overexpression, a theoretical cancer stem cells (CSCs) marker, have been shown to induce colorectal cancer (CRC) initiation and relapse. Therefore, the detection and treatment of CSCs are the most important factors in overcom...

see more →

News  2,353 results

Now USPSTF Also Suggests Start CRC Screening at Age 45
https://www.medscape.com/viewarticle/939820

Oct 26th, 2020 - Screening for colorectal cancer (CRC) should begin at age 45 years instead of 50 years, as recommended in the current guideline, the US Preventive Services Task Force (USPSTF) says in a draft recommendation that is open for public comment. "This i...

Colorectal Cancer More Likely After First Acute Diverticulitis
https://www.staging.medscape.com/viewarticle/939507

Oct 21st, 2020 - NEW YORK (Reuters Health) - Acute diverticulitis, a leading cause of U.S. hospital admissions, is associated with an increased risk of subsequent colorectal cancer (CRC), according to a large population-based study. "We found that there was an alm...

Delayed Cancer Screening Could Cause Increase in Deaths, Study Says
https://www.medscape.com/viewarticle/938990

Oct 11th, 2020 - Delays in colorectal cancer screening due to the COVID-19 pandemic could lead to higher rates of advanced-stage cancer and death, according to a new study. When compared with a delay of less than three months, the longer delay seen this year may r...

Colonoscopy Patients May Get Hit With a 'Surprise Bill'
https://www.medscape.com/viewarticle/938994

Oct 11th, 2020 - A colonoscopy screening for colorectal cancer should be covered by commercial health insurance, but a new study reports that some patients receive a 'surprise' bill. The study was published online today as a research letter in the Annals of Intern...

Delayed Cancer Screening Could Cause Increase in Deaths, Study Says
https://www.staging.medscape.com/viewarticle/938990

Oct 11th, 2020 - Delays in colorectal cancer screening due to the COVID-19 pandemic could lead to higher rates of advanced-stage cancer and death, according to a new study. When compared with a delay of less than three months, the longer delay seen this year may r...

see more →

Patient Education  65 results see all →